Health & Biotech
Check out the latest Biotech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
ASX innovators reshaping traditional medical treatments
Stockhead TV
Long Shortz with AdAlta: Global health experts recruited for idiopathic pulmonary fibrosis drug
Stockhead TV
Long Shortz with Lumos Diagnostics: Attention from the globe as antimicrobial resistance takes flight
Health & Biotech
Amplia CEO co-recipient of 2024 Prime Minister’s Prize for Innovation
Stockhead TV
Long Shortz with Orthocell: Gateway to Asia open with Singapore market entry
Health & Biotech
ASX medical disruptors pioneering new diagnostics and cutting-edge procedures
Health & Biotech
Recce’s Phase 2 trial for skin infections hits midway recruitment milestone
Health & Biotech
Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market
Health & Biotech
Orthocell secures regulatory approval to launch Remplir sales in Singapore
Health & Biotech
Health Check: Lion City’s Orthocell approval provides a Singapore Sling-board to Asian markets
Health & Biotech
Orthocell delivers second quarter of record revenue
Health & Biotech
Health Kick Podcast: TrivarX hones the connection between sleep and depression
Health & Biotech
Dr Boreham’s Crucible: A stroke-scanning player targeting unmet medical need and a massive market
Stockhead TV
Tony’s Takeaway: Biotech buffet on the ASX
Health & Biotech
Health Check: Long-suffering Mesoblast investors dare to dream
Health & Biotech
Scott Power: This sleep devices maker is dreaming big with its 2030 strategy
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
Health & Biotech
Health Check: Farewell, adieu as Argent Biopharma holders back ASX delisting
Health & Biotech
September Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
Health & Biotech
Bio Curious: ‘Best-kept secret in Australian healthcare’ spruiks its telehealth credentials
Health & Biotech
Health Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging deal
Health & Biotech
Health Check: Probiotics supplier has gut feeling about surging growth
Health & Biotech
Scott Power: Which health ‘underperformer’ just made a big move?
Health & Biotech
Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health & Biotech
Health Kick Podcast: Talking antibiotics with Recce Pharmaceuticals
Health & Biotech
ASX health stocks capitalise on growing Southeast Asian market
Health & Biotech
Broker Upgrades: Earnings season reveals gems, and Telix and CSL are ones to watch
Health & Biotech
Health Check: Cancer drug developer Chimeric heads to blood bank for better patient cells
Health & Biotech
Health Kick Podcast: Singular Health Group’s software solution
Health & Biotech
Health Check: Experts deliver their verdict on the Healius imaging deal and it’s ‘yeah nah’
Health & Biotech
HealthInvest 2024: The biotech sector looks in rude health, judging by these five ASX innovators
Health & Biotech
Virtual reality medical imaging Singular Health up 117pc YTD as key investors climb aboard
Health & Biotech
Health Check: Proteomics reports ‘excellent’ results for blood-based esophageal cancer test
Experts
Dr Boreham’s Crucible: The market is there for this innovative lymphoedema detector to win… or lose
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but there’s ‘wind in the sails again’
Health & Biotech
ASX stocks leading clinical trials in Australia
Health & Biotech
MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs
Health & Biotech
Health Check: Medical pot play Cann Group sees an earnings turnaround through the haze
Stockhead TV
Break it Down: Paradigm Biopharmaceuticals en route to Phase 3 clinical trial with FDA support
Health & Biotech
Broker Upgrades: 4DMedical could take off with big US opportunities and deal with Philips
Health & Biotech
‘Holy Grail’ – Alterity Therapeutics aims to slow progression of Parkinson’s disease
Health & Biotech
Health Check: Paradigm receives FDA guidance on proposed trial for dodgy knees
Health & Biotech
Australia proves its reputation as ‘go-to’ destination for clinical trials
Health & Biotech
Bio Curious: Phone autism test strives to make diagnosis quicker and more blinkin’ simple
Health & Biotech
Alive and Kicking: No sweat as Botanix readies for US launch of its hyperhidrosis treatment
Health & Biotech
Alive and Kicking: Respiri promises breath of life to bottom line after inking US distribution deal
Experts
Dr Boreham’s Crucible: It’s no pain, no gain for this MVP, but can it finally become the GOAT?
Load More